KRAS and cancer: By using the similar approach, inhibition of MAPK7, an essential MEK gene, attenuated the re-activation of MAPK signaling following long-term MEK inhibition in KRAS mutant cancer cells, suggesting that targeting MAPK7 may attenuate acquired resistance to MEK inhibition (158).